Steven A McCarroll Selected Research

Complement C4 (Complement Component 4)

1/2022	Author Correction: Schizophrenia risk from complex variation of complement component 4.
1/2021	Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice.
2/2016	Schizophrenia risk from complex variation of complement component 4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven A McCarroll Research Topics

Disease

12	Schizophrenia (Dementia Praecox) 01/2022 - 03/2014
6	Neoplasms (Cancer) 01/2022 - 12/2014
3	AIDS-Related Complex (ARC) 03/2017 - 02/2014
2	Neurodevelopmental Disorders 01/2022 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 11/2020
2	Obesity 08/2015 - 02/2015
2	Insulin Resistance 01/2012 - 02/2010
2	Type 2 Diabetes Mellitus (MODY) 01/2012 - 02/2010
1	Aneuploidy (Aneuploid) 01/2022
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Genetic Risk Score 01/2021
1	Communicable Diseases (Infectious Diseases) 11/2020
1	Multiple Myeloma 01/2020
1	Smoldering Multiple Myeloma 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2019
1	Genomic Instability 11/2019
1	Brain Injuries (Brain Injury) 01/2019
1	Pathologic Constriction (Stenosis) 11/2018
1	Philadelphia Chromosome 11/2018
1	Thrombosis (Thrombus) 11/2018
1	Chronic Renal Insufficiency 01/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2018
1	Anemia 01/2018
1	Sickle Cell Trait 01/2018
1	Thalassemia 01/2018
1	Stroke (Strokes) 01/2018
1	Hypersensitivity (Allergy) 11/2014
1	Autistic Disorder (Autism) 02/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2009
1	Crohn Disease (Crohn's Disease) 01/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2014
3	Complement C4 (Complement Component 4)IBA 01/2022 - 02/2016
3	Biological ProductsIBA 01/2021 - 01/2019
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 02/2014
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Complement System Proteins (Complement)IBA 01/2020 - 02/2016
1	dichlorobis(azomycin)platinum IIIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Complement C4aIBA 01/2021
1	FurinIBA 01/2021
1	ruxolitinibIBA 11/2018
1	Janus KinasesIBA 11/2018
1	GlobinsIBA 01/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 03/2017
1	LeptinIBA 03/2017
1	Peptides (Polypeptides)IBA 03/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2017
1	Amylases FDA Link 08/2015
1	LipidsIBA 02/2015
1	Glutamic Acid (Glutamate)FDA Link 02/2015
1	di-n-hexyl sulfosuccinate (DHSS)IBA 11/2014
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 03/2014
1	Calcium Channels (Calcium Channel)IBA 02/2014
1	NucleotidesIBA 02/2014
1	Fragile X Mental Retardation ProteinIBA 02/2014
1	Hormones (Hormone)IBA 01/2012
1	AdiponectinIBA 01/2012
1	Insulin (Novolin)FDA Link 02/2010
1	Glucose (Dextrose)FDA LinkGeneric 02/2010
1	GTP Phosphohydrolases (GTPases)IBA 01/2009

Therapy/Procedure

1	Transcutaneous Electric Nerve Stimulation (TENS) 10/2020
1	Therapeutics 11/2019
1	Hematopoietic Stem Cell Transplantation 12/2009